Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2015 Dec 21;151(5):1380–1388. doi: 10.1016/j.jtcvs.2015.12.028

Figure 3A.

Figure 3A

Overall Survival of Patients with Unsuspected vs. Suspected N2 NSCLC. Patients with “unsuspected N2” disease had underwent lobectomy as primary therapy for cT1-3 N0-1 NSCLC and were found to have pN2 disease at the time of surgery. Patients with “suspected N2” disease had clinical stage IIIA-N2 NSCLC who underwent induction chemotherapy ± radiation followed by lobectomy.